Paperpal Prime Logo

Japanese Journal of Clinical Oncology : Impact Factor & More

eISSN: 1465-3621pISSN: 0368-2811

Key Metrics

CiteScore
3.9
H-Index
93
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.12
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Japanese Journal of Clinical Oncology

Japanese Journal of Clinical Oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • SJR SJR
Overview
Publisher OXFORD UNIV PRESS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1971
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Japanese Journal of Clinical Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Japanese Journal of Clinical Oncology

Prognostic impact of regional lymph node metastasis at castration-resistant prostate cancer diagnosis on survival after radium-223 treatment.
  • 7 Aug 2026
  • Japanese journal of clinical oncology
Prognostic significance of non-muscle-invasive late recurrence after intravesical bacillus Calmette-Guérin therapy in bladder cancer: a multicenter, retrospective real-world study (the Japan Urological Oncology Group).
  • 7 Aug 2026
  • Japanese journal of clinical oncology
Bayesian reanalysis of the NIAGARA trial using reconstructed individual patient data: perioperative durvalumab in cisplatin-eligible muscle-invasive bladder cancer.
  • 5 Aug 2026
  • Japanese journal of clinical oncology
Global evidence and clinical implications of spontaneous tumor lysis syndrome in older adults with solid tumors: a systematic review of reported cases.
  • 5 Aug 2026
  • Japanese journal of clinical oncology
Impact of prior nivolumab on treatment outcomes of taxane plus ramucirumab in advanced gastric cancer.
  • 5 Aug 2026
  • Japanese journal of clinical oncology
Optimizing management of small renal masses: a patient-centered approach to minimize overtreatment.
  • 5 Aug 2026
  • Japanese journal of clinical oncology
Prognostic impact of regional lymph node metastasis at castration-resistant prostate cancer diagnosis on survival after radium-223 treatment.
  • 7 Aug 2026
  • Japanese journal of clinical oncology
Prognostic significance of non-muscle-invasive late recurrence after intravesical bacillus Calmette-Guérin therapy in bladder cancer: a multicenter, retrospective real-world study (the Japan Urological Oncology Group).
  • 7 Aug 2026
  • Japanese journal of clinical oncology
Bayesian reanalysis of the NIAGARA trial using reconstructed individual patient data: perioperative durvalumab in cisplatin-eligible muscle-invasive bladder cancer.
  • 5 Aug 2026
  • Japanese journal of clinical oncology
Global evidence and clinical implications of spontaneous tumor lysis syndrome in older adults with solid tumors: a systematic review of reported cases.
  • 5 Aug 2026
  • Japanese journal of clinical oncology
Impact of prior nivolumab on treatment outcomes of taxane plus ramucirumab in advanced gastric cancer.
  • 5 Aug 2026
  • Japanese journal of clinical oncology
Optimizing management of small renal masses: a patient-centered approach to minimize overtreatment.
  • 5 Aug 2026
  • Japanese journal of clinical oncology

FAQs on Japanese Journal of Clinical Oncology